30 mCi Radioiodine Treatment of Thyroid Carcinoma Patients in the post ESTIMABL Era

被引：0
|
作者：
Rusu, D. [1 ]
Fleury, V. [1 ]
Palpacuer, C. [2 ]
Le Thiec, M. [1 ]
Colombie, M. [1 ]
Kraeber-Bodere, F. [1 ,3 ,4 ]
Rousseau, C. [1 ,4 ]
机构：
[1] ICO Canc Fighting Ctr, Nucl Med, St Herblain, France
[2] ICO Canc Fighting Ctr, Stat Unit, St Herblain, France
[3] Univ Hosp, Nucl Med, Nantes, France
[4] CNRS, INSERM, CRCNA, U892,UMR 6299, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-568
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [21] Lung toxicity in radioiodine therapy of thyroid carcinoma: dosimetric implications of the 80 mci rule
    Sgouros, G.
    Song, H.
    Ladenson, P. W.
    Wahl, R. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S102 - S102
  • [22] Radioiodine and thyroid carcinoma: 30 years experience in Homburg/Saar
    Alexander, C
    Schaefer, A
    Finke, C
    Kirsch, CM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (01): : S103 - S103
  • [23] Results of multidisciplinary treatment, including radioiodine, in pediatric patients with differentiated thyroid carcinoma
    Stefanovic, L.
    Mihailovic, J.
    Matovina, E.
    Malesevic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S320 - S321
  • [24] Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma
    Dai, Xin
    Ren, Xinyi
    Zhang, Jinyu
    Zheng, Yuxin
    Wang, Zhengjie
    Cheng, Gang
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (09) : 688 - 699
  • [25] Prediction of Radioiodine Treatment Results in Patients with Well-Differentiated Thyroid Carcinoma
    Kowalczyk, A.
    Kaminski, G.
    Jurczyk, M.
    Szalus, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S196 - S196
  • [26] Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes
    Kukulska, Aleksandra
    Krajewska, Jolanta
    Gawkowska, Marzena
    Paliczka-Cieslik, Ewa
    Handkiewicz-Junak, Daria
    Kropinska, Aleksandra
    Puch, Zbigniew
    Olczyk, Tomasz
    Roskosz, Jozef
    Jarzab, Barbara
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (05) : 1241 - 1247
  • [27] Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma
    Chung J.-K.
    Youn H.W.
    Kang J.H.
    Lee H.Y.
    Kang K.W.
    Nuclear Medicine and Molecular Imaging, 2010, 44 (1) : 4 - 14
  • [28] Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma
    Cheng, Lingxiao
    Liu, Min
    Ruan, Maomei
    Chen, Libo
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (01) : 23 - 32
  • [29] THE USE OF THIOURACIL IN THE TREATMENT OF METASTATIC CARCINOMA OF THE THYROID WITH RADIOIODINE
    RALL, JE
    MILLER, WN
    FOSTER, CG
    PEACOCK, WC
    RAWSON, RW
    JOURNAL OF CLINICAL ENDOCRINOLOGY, 1951, 11 (11): : 1273 - 1280
  • [30] Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma
    Yuan, Leilei
    Yang, Jigang
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (11-12): : 877 - 883
12345